Ieq Capital LLC Sells 222 Shares of SPDR S&P Biotech ETF $XBI

Ieq Capital LLC reduced its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 4,369 shares of the exchange traded fund’s stock after selling 222 shares during the period. Ieq Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $354,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Bourgeon Capital Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 6.1% during the 1st quarter. Bourgeon Capital Management LLC now owns 2,822 shares of the exchange traded fund’s stock worth $229,000 after buying an additional 163 shares during the last quarter. First Heartland Consultants Inc. lifted its position in shares of SPDR S&P Biotech ETF by 2.7% during the 1st quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock worth $514,000 after buying an additional 168 shares during the last quarter. Arlington Financial Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 0.8% during the 1st quarter. Arlington Financial Advisors LLC now owns 22,685 shares of the exchange traded fund’s stock worth $1,840,000 after buying an additional 181 shares during the last quarter. Institute for Wealth Management LLC. raised its position in SPDR S&P Biotech ETF by 2.0% in the first quarter. Institute for Wealth Management LLC. now owns 9,676 shares of the exchange traded fund’s stock valued at $785,000 after purchasing an additional 186 shares during the last quarter. Finally, Private Trust Co. NA boosted its stake in shares of SPDR S&P Biotech ETF by 7.0% during the first quarter. Private Trust Co. NA now owns 2,834 shares of the exchange traded fund’s stock valued at $230,000 after purchasing an additional 186 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 2.1%

Shares of XBI stock opened at $95.47 on Friday. The business’s 50-day moving average price is $87.83 and its 200-day moving average price is $83.94. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47. The firm has a market capitalization of $5.20 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.